ONO PHARMACEUT./ JP3197600004 /
| 17/05/2024 08:00:37 | Chg. +0.100 | Volume | Bid21:58:01 | Ask21:58:01 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 13.400EUR | +0.75% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 7.5 bill.EUR | - | - |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 230.85 JPY | 42.33% |
| EPS Diluted: | - JPY | 42.32% |
| Revenues per Share: | 864.25 JPY | 26.36% |
| Book Value per Share: | 1,433.77 JPY | 15.49% |
| Cash Flow per Share: | 308.47 JPY | 163.59% |
| Dividend per Share: | 70.00 JPY | 25.00% |
| Total | in mill. | |
| Revenues: | 447,187.00 JPY | 23.75% |
| Net Income: | 112,721.00 JPY | 39.99% |
| Operating Cash Flow: | 159,610.00 JPY | - |
| Cash and Cash Equivalents: | 96,135.00 JPY | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 9.81 | 11.97 |
| P/S Ratio: | 2.62 | 3.20 |
| P/BV ratio: | 1.58 | 1.93 |
| P/CF Ratio: | 7.34 | 8.96 |
| PEG: | 0.23 | 0.28 |
| Earnings Yield: | 10.20% | 8.35% |
| Dividend Yield: | 3.09% | 2.53% |
| Market Capitalization | ||
| Market Capitalization: | 7.5 bill. EUR | 10.15 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 2.03 mill. EUR | 2.74 mill. EUR |
| Shares Outstanding: | 517.43 mill. | |
Profitability
| Gross Profit Margin: | 75.39% |
| EBIT Margin: | 31.75% |
| Net Profit Margin: | 25.21% |
| Return on Equity: | 15.19% |
| Return on Assets: | 12.77% |
Financial Strength
| Liquidity I / Cash Ratio: | 78.20% |
| Liquidity II / Quick Ratio: | 171.26% |
| Liquidity III / Current Ratio: | 280.73% |
| Debt / Equity Ratio: | 18.95% |
| Dynam. Debt / Equity Ratio: | 88.07% |
Efficiency
| Employees: | 3,700 |
| Personal Expenses / Employee: | - JPY |
| Revenues / Employee: | 120,861,351.35 JPY |
| Net Income / Employee: | 30,465,135.14 JPY |
| Total Assets / Employee: | 238,496,486.49 JPY |
| * Fiscal Year End: | 31/03/2023 |
| Accounting Standard: | IFRS |
| Currency: | JPY |
